National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C05AA01	SEDIPROCT	G	Hydrocortisone - 500mg, Cinchocaine HCl - 500mg		Cream	290,270 L.L
D10AF05	NADIXA	G	Nadifloxacin - 1%	1%	Cream	850,652 L.L
C05AX05	PROCTO GLYVENOL	B	Lidocaine HCl - 2g/100g, Tribenoside - 5g/100g		Cream	405,840 L.L
D10AX03	SKINOREN	B	Azelaic acid - 0.2g/g	0.2g/g	Cream	722,987 L.L
D11AH02	ELIDEL	B	Pimecrolimus - 10mg/g	1%	Cream	1,780,591 L.L
L01BC02	EFUDIX	B	Fluorouracil - 5%	5%	Cream	671,921 L.L
D11AX11	AVOQUIN	G	Hydroquinone - 4%	4%	Cream	916,501 L.L
D11AX16	FLOREXA	G	Eflornithine (HCl) - 11.5%	11.5%	Cream	3,527,587 L.L
D11AX22	SOOLANTRA	B	Ivermectin - 10mg/g	10mg/g	Cream	2,154,180 L.L
D11AX22	SOOLANTRA	B	Ivermectin - 10mg/g	10mg/g	Cream	1,053,573 L.L
G01AF04	MYCODERM-V	G	Miconazole nitrate - 2%	2%	Cream	361,494 L.L
D01AC01	CANESTEN	B	Clotrimazole - 0.01g/g	0.01g/g	Cream	344,024 L.L
D01AC02	DAKTARIN	B	Miconazole nitrate - 20mg/g	20mg/g	Cream	231,141 L.L
D01AC03	ECONAZ	G	Econazole nitrate - 1%	1%	Cream	307,164 L.L
D01AC12	LOMEXIN	B	Fenticonazole nitrate - 2g/100g	2%	Cream	729,154 L.L
D01AC14	DERMOFIX	B	Sertaconazole nitrate - 20mg/g	2%	Cream	382,995 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 1%	1%	Cream	284,895 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/g	1%	Cream	616,824 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/g	1%	Cream	616,824 L.L
D01AE15	LAMIFEN	G	Terbinafine HCl - 1%	1%	Cream	321,178 L.L
D01AE15	LAMINOX	G	Terbinafine HCl - 10mg/g	10mg/g	Cream	453,067 L.L
D01AE15	TERAFAN	G	Terbinafine HCl - 1%	1%	Cream	499,142 L.L
D01AE22	EXODERIL	B	Naftifine HCl - 10mg/g	1%	Cream	345,368 L.L
G03CA03	MONTADIOL	G	Estradiol - 0.01%	0.01%	Cream	1,105,982 L.L
D03AX	BEPANTHEN PLUS	B	Chlorhexidine HCl - 5mg/g, Dexpanthenol - 50mg/g		Cream	319,835 L.L
D04AA32	DERMAMINE ITCH STOPPING	G	Diphenhydramine HCl - 1%, Zinc acetete - 0.1%		Cream	560,382 L.L
D04AA32	HISTERGAN	G	Diphenhydramine HCl - 2%	2%	Cream	546,944 L.L
D06AX01	FUCIDIN	B	Fusidic acid - 20mg/g	2%	Cream	259,362 L.L
D06AX01	FUCIDIN CREAM	B	Fusidic acid - 2%	2%	Cream	491,846 L.L
D06AX01	FUCIDIN CREAM	B	Fusidic acid - 2%	2%	Cream	345,368 L.L

National Cancer Registry (NCR)